Rosheen Caw
About Rosheen Caw
Rosheen Caw serves as the Senior Director of Business Operations for the UK, France, and Germany at Asklepios BioPharmaceutical, Inc. since 2014, bringing over two decades of experience in business operations and management across various roles in the financial services sector.
Work at Asklepios BioPharmaceutical
Rosheen Caw has served as the Senior Director of Business Operations for the UK, France, and Germany at Asklepios BioPharmaceutical, Inc. (AskBio) since 2014. In this role, she is responsible for overseeing business operations across these key European markets. Her leadership has been instrumental in driving operational efficiency and aligning business strategies with corporate goals. Based in Edinburgh, United Kingdom, she has contributed to the company's growth and operational success in the biopharmaceutical sector.
Previous Experience at Standard Life
Prior to her current role, Rosheen Caw held various positions at Standard Life. She began her career there as a Customer Service Manager from 1991 to 2001, followed by roles as Business Development Manager (UK Distribution) from 2002 to 2006, and Deal & Acquisition Manager (UK) from 2006 to 2010. She later served as Head of Retail Operations (UK) from 2010 to 2012. These roles provided her with extensive experience in managing operations and customer service within the financial services industry.
Education and Expertise
Rosheen Caw studied Financial Economics at The University of Dundee, where she earned her MA Honours from 1989 to 1991. She furthered her education by obtaining a Master of Business Administration (M.B.A.) from The Open University Business School, completing her studies from 1993 to 1999. Her academic background supports her comprehensive understanding of financial and operational strategies necessary for driving successful business outcomes.
Leadership Style and Operational Insight
Rosheen Caw is recognized for her pragmatic and open leadership style, which has enabled her to effectively drive change within organizations. She possesses a comprehensive understanding of the actions and financials required to create shareholder value. Her extensive experience managing business operations across multiple European countries, specifically the UK, France, and Germany, enhances her ability to navigate complex operational challenges in the biopharmaceutical industry.